WWAY TV2h
Even with access to blockbuster obesity drugs, some people don’t lose weight
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...
Are Hedge Funds Betting Big on Novo Nordisk (NVO)’s Diabetes and Chronic Disease Care?
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
Ozempic’s maker wants the US government to ban cheaper versions of the high-priced $969 injection weight-loss drug – claims the formula is ‘too complex’ to cop…
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
devdiscourse15h
FDA's Game-Changing Approvals and Global Health Alerts
The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundup
Oura smart rings will soon be able to help users track their blood sugar levels through a new partnership with Dexcom (DXCM), ...
Investor's Business Daily on MSN23h
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.
Kennedy Doesn’t Like Ozempic. Here’s What He Can Do About It.
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...